42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-1115067
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 4c1d903a-b96c-4153-9ad9-717877db77f4
[Document ID] => 1115067
[Document naam] => COHET_Observational COVID-19 vaccine safety studies 04FEB21.pptx
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/document/VWS-WOO-08-1115067
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-1115067
[Status] =>
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo
[DocumentPublicationDate] => 4 februari 2021
[DocumentStatusCheckedDate] =>
[DocumentStatusCheckedResult] =>
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 06:11:38
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 06:11:38
)
Document: VWS-WOO-08-1115067
Klik om te vergroten
Document correcties
Geregistreerde datum: 20210204
Geregistreerde documentnaam: COHET_Observational COVID-19 vaccine safety studies 04FEB21.pptx
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:40:13 |
| Request_Omvang openbaarmaking_documenten | 13.418 | 2025-06-22 23:40:13 |
| Request_Omvang openbaarmaking_paginas | 24.551 | 2025-06-22 23:40:13 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/file/download/inventory | 2025-06-22 23:40:13 |
| document_SectionRelated | 1 | 2025-06-22 23:40:13 |
| document_documentName | COHET_Observational COVID-19 vaccine safety studies 04FEB21.pptx | 2025-06-22 23:40:13 |
| document_documentType | Presentatie | 2025-06-22 23:40:13 |
| document_documentPublicationDate | 2021-02-04 | 2025-06-22 23:40:13 |
| document_documentNumber | VWS-WOO-08-1115067 | 2025-06-22 23:40:13 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:40:13 |
| document_SectionHTMLDataDivs | 3 | 2025-06-22 23:40:13 |
| document_SectionAbout | 1 | 2025-06-22 23:40:13 |
| About_Datum document | 4 februari 2021 | 2025-06-22 23:40:13 |
| About_Type bronbestand | Presentatie, 15 pagina's | 2025-06-22 23:40:13 |
| About_Type bronbestand_paginas | 15 | 2025-06-22 23:40:13 |
| About_Download als | PDF (5.54 MB) | 2025-06-22 23:40:13 |
| About_Documentnummer | 1115067 | 2025-06-22 23:40:13 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:40:13 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over COHET_Observational COVID-19 vaccine safety studies 04FEB21.pptx (documentnummer 1ee694d5-48d7-6b24-868a-15d4a7a92981) | 2025-06-22 23:40:13 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:40:13 |
| document_SectionRequest | 1 | 2025-06-22 23:40:13 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode februari 2021 | 2025-06-22 23:40:13 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo | 2025-06-22 23:40:13 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode februari 2021 | 2025-06-22 23:40:13 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 21 december 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode februari 2021. | 2025-06-22 23:40:13 |
| Request_Periode | Februari 2021 | 2025-06-22 23:40:13 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:40:13 |
| Request_Datum besluit | 21 december 2022 | 2025-06-22 23:40:13 |
| Request_Omvang openbaarmaking | 13.418 documenten, 24.551 pagina's Inventarislijst | 2025-06-22 23:40:13 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3478791-1040904-pdo/file/download/document/1ee694d5-48d7-6b24-868a-15d4a7a92981 | 2025-04-19 22:25:26 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-1115067.pdf | 2025-04-19 22:25:26 |
| DocumentDownload_linkname | Download (pdf, 5.54 MB) | 2025-04-19 22:25:26 |
Archiefversies (7 rijen)
Archiefrij 1 — 2025-10-22 14:09:58
fromFile: VWS-WOO-3478791-1040904-pdo-1f0a5062-ca80-6d9e-ad03-555512cbea5c.zip
fromFilePath: /volume3/websites/openrijksoverheid/archieven_files/VWS-WOO-3478791-1040904-pdo-1f0a5062-ca80-6d9e-ad03-555512cbea5c.zip
documentName: VWS-WOO-08-1115067.pdf
documentType: pdf
documentCompressedSize: 3349944
documentSize: 5810040
documentCompressRatio: 57.65784745027573
documentDateModified: 2025-10-09 12:01:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-10-22 14:09:58
lastSeen: 2025-10-22 14:09:58
text: 1115067 Oo Observational COVID-19 vaccine safety studies: preparedness, ongoing and planned studies EU-EEA NITAG collaboration webinar on COVID-19 vaccine safety Presented on 04 a il 1115067 © Monitoring vaccine safety in real-life through observational studies Vaccine develop...
noTextDate: leeg!
ocrText: Datum: vrijdag 20 augustus 2021 12:16:00 Beste ‚ Eigenlijk zou ik hierover graag een afspraak aan tafel willen. Ik wil graag weten wat de inspectie allemaal doet op dit moment, of dat het hele repertoire is, en of dat echt full force wordt ingezet. Verhalen die de ronde doen (hoor ik uiteraard sl...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: f00769c841ed47266168232153405068ffa6358bd1e9ab13bc0c52ce3c4fad61
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3478791-1040904-pdo-1f0a5062-ca80-6d9e-ad03-555512cbea5c.zip_5266
textDigestSHA256: b2eed134583c88c7c1cc225b3d7f54bc8fc636209da4b5398de25fbb01ddc9a3
ocrTextDigestSHA256: 0a8c0a926625c74214e56cdceb471d6743facdaf9a019f0c13d9c21860bda4bf
extractedId: VWS-WOO-08-1115067
Archiefrij 2 — 2025-09-07 17:27:44
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1115067.pdf
documentName: VWS-WOO-08-1115067.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 5810040
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:27:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:27:44
lastSeen: 2025-09-07 17:27:44
text: 1115067
Oo
Observational COVID-19 vaccine safety studies:
preparedness, ongoing and planned studies
EU-EEA NITAG collaboration webinar onCOVID-19 vaccine safety
Presented on04ail1115067
©
Monitoring vaccine safetyinreal-life through observational studies
i
Vaccine inuse$Vaccine development phases
[|...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: f00769c841ed47266168232153405068ffa6358bd1e9ab13bc0c52ce3c4fad61
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_54442_55b25cb7ccc8a3d496fa860423b0df92
textDigestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1115067
Archiefrij 3 — 2025-09-04 17:04:53
fromFile: VWS-WOO-3478791-1040904-pdo-1f026c98-b2f7-6926-8f52-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3478791-1040904-pdo-1f026c98-b2f7-6926-8f52-65673e0af118.zip
documentName: VWS-WOO-08-1115067.pdf
documentType: pdf
documentCompressedSize: 3349944
documentSize: 5810040
documentCompressRatio: 57.65784745027573
documentDateModified: 2025-05-01 20:41:34
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:04:53
lastSeen: 2025-09-04 17:04:53
text: 1115067
Oo
Observational COVID-19 vaccine safety studies:
preparedness, ongoing and planned studies
EU-EEA NITAG collaboration webinar onCOVID-19 vaccine safety
Presented on04ail1115067
©
Monitoring vaccine safetyinreal-life through observational studies
i
Vaccine inuse$Vaccine development phases
[|...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: f00769c841ed47266168232153405068ffa6358bd1e9ab13bc0c52ce3c4fad61
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: VWS-WOO-3478791-1040904-pdo-1f026c98-b2f7-6926-8f52-65673e0af118.zip_3533
textDigestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1115067
Archiefrij 4 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3478791-1040904-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3478791-1040904-pdo.zip
documentName: VWS-WOO-08-1115067-COHET_Observational_COVID-19_vaccine_safety_studies__04FEB21.pptx.pdf
documentType: pdf
documentCompressedSize: 3343475
documentSize: 5810040
documentCompressRatio: 57.54650570391943
documentDateModified: 2024-11-19 14:51:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: 1115067
Oo
Observational COVID-19 vaccine safety studies:
preparedness, ongoing and planned studies
EU-EEA NITAG collaboration webinar onCOVID-19 vaccine safety
Presented on04ail1115067
©
Monitoring vaccine safetyinreal-life through observational studies
i
Vaccine inuse$Vaccine development phases
[|...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 335859
textDigestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1115067
Archiefrij 5 — 2025-02-27 09:25:05
fromFile: 2023.057-VWS-WOO-3478791-1040904-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3478791-1040904-pdo.zip
documentName: VWS-WOO-08-1115067-COHET_Observational_COVID-19_vaccine_safety_studies__04FEB21.pptx.pdf
documentType: pdf
documentCompressedSize: 3343475
documentSize: 5810040
documentCompressRatio: 57.54650570391943
documentDateModified: 2024-11-19 14:51:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:05
lastSeen: 2025-02-27 09:25:05
text: 1115067
Oo
Observational COVID-19 vaccine safety studies:
preparedness, ongoing and planned studies
EU-EEA NITAG collaboration webinar onCOVID-19 vaccine safety
Presented on04ail1115067
©
Monitoring vaccine safetyinreal-life through observational studies
i
Vaccine inuse$Vaccine development phases
[|...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 6144, "email": "IEE@cna.curopa.eu", "context": "foryour attention Questions: IEE@cna.curopa.eu European Medicines Agency"}]
documentMailAdresses: [{"position": 6144, "email": "IEE@cna.curopa.eu", "context": "foryour attention Questions: IEE@cna.curopa.eu European Medicines Agency"}]
digestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 248947
textDigestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1115067
Archiefrij 6 — 2025-02-18 12:18:13
fromFile: Besluit__dossier_nr_-6c83ab2d51cf026ac610ece2faff887a7ba1a1fe4e877e2c6b36655c00305357.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-6c83ab2d51cf026ac610ece2faff887a7ba1a1fe4e877e2c6b36655c00305357.zip
documentName: VWS-WOO-08-1115067-COHET_Observational_COVID-19_vaccine_safety_studies__04FEB21.pptx.pdf
documentType: pdf
documentCompressedSize: 3343475
documentSize: 5810040
documentCompressRatio: 57.54650570391943
documentDateModified: 2024-11-19 14:51:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 1115067
Oo
Observational COVID-19 vaccine safety studies:
preparedness, ongoing and planned studies
EU-EEA NITAG collaboration webinar onCOVID-19 vaccine safety
Presented on04ail1115067
©
Monitoring vaccine safetyinreal-life through observational studies
i
Vaccine inuse$Vaccine development phases
[|...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 6144, "email": "IEE@cna.curopa.eu", "context": "foryour attention Questions: IEE@cna.curopa.eu European Medicines Agency"}]
documentMailAdresses: [{"position": 6144, "email": "IEE@cna.curopa.eu", "context": "foryour attention Questions: IEE@cna.curopa.eu European Medicines Agency"}]
digestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 118571
textDigestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1115067
Archiefrij 7 — 2025-02-18 12:18:00
fromFile: Besluit__dossier_nr_-059f008949175bc5c1c05e6900ee06a7b0f3f1edfa07b5d2ec14c9ecfa5c5bc7.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-059f008949175bc5c1c05e6900ee06a7b0f3f1edfa07b5d2ec14c9ecfa5c5bc7.zip
documentName: VWS-WOO-08-1115067-COHET_Observational_COVID-19_vaccine_safety_studies__04FEB21.pptx.pdf
documentType: pdf
documentCompressedSize: 3343475
documentSize: 5810040
documentCompressRatio: 57.54650570391943
documentDateModified: 2024-08-30 08:45:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:00
lastSeen: 2025-02-18 12:18:00
text: 1115067
Oo
Observational COVID-19 vaccine safety studies:
preparedness, ongoing and planned studies
EU-EEA NITAG collaboration webinar onCOVID-19 vaccine safety
Presented on04ail1115067
©
Monitoring vaccine safetyinreal-life through observational studies
i
Vaccine inuse$Vaccine development phases
[|...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 6144, "email": "IEE@cna.curopa.eu", "context": "foryour attention Questions: IEE@cna.curopa.eu European Medicines Agency"}]
documentMailAdresses: [{"position": 6144, "email": "IEE@cna.curopa.eu", "context": "foryour attention Questions: IEE@cna.curopa.eu European Medicines Agency"}]
digestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 19427
textDigestSHA256: ec291f8ebe66cd1d30e4bbdae474554ba1cc59664c8b90cb44b094b94ddf06a0
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1115067
(dit is ook een speeltuin)